{"id":"clm_408FF4DCACA7","entity":"abbott-laboratories","predicate":"total_assets","value":"108,247,000,000 United States dollar","value_json":{"fp":"Q3","fy":2026,"accn":"0001628280-26-070154","form":"10-Q","filed":"2026-11-04","period":"Q3 FY2026","concept":"us-gaap:Assets"},"valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Abbott Laboratories total assets: 108,247,000,000 United States dollar\", as of 2026-09-30. Claim clm_408FF4DCACA7, https://asof.is/claim/clm_408FF4DCACA7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm.","url":"https://asof.is/claim/clm_408FF4DCACA7","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"supersedes":["clm_9F11A9C39281"],"first_seen_at":"2026-11-08T16:56:09.404533+00:00","updated_at":"2026-11-08T16:56:09.404533+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}